Results 131 to 140 of about 8,337 (255)

Whole-exome sequencing in pediatric patients with glomerulonephritis. [PDF]

Front Genet
Peric M, Brankovic M, Stajic N, Putnik J, Paripovic A, Jankovic M, Nikolic D, Milanovic F, Novakovic I, Vukomanovic V.   +9 more
europepmc   +1 more source

Identifying High‐Impact Solutions to Address Racial and Ethnic Health Disparities in Lupus: A Consensus‐Based Approach

Arthritis Care &Research, Volume 78, Issue 3, Page 371-377, March 2026.
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health (SDoH). Methods We conducted a search for keywords, which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the
Joy Buie, Michael P. Fisher, Kristen Backor, Hannah Tyldsley, Ashira Blazer, Candace Feldman, Andrea Knight, S. Sam Lim, Barbara Ann Polk, Ed Yelin, Edith Williams, Karen H. Costenbader   +11 more
wiley   +1 more source

Crossed Erythrocytes Agglutination Pattern Observed in a Patient With Hereditary Elliptocytosis. [PDF]

Int J Lab Hematol
Melo MAW, Silveira CM, Ribeiro MM, Arcanjo GS.   +3 more
europepmc   +1 more source

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

Arthritis Care &Research, Volume 78, Issue 3, Page 378-387, March 2026.
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao, Dylan Hansen, Rangi Kandane‐Rathnayake, Worawit Louthrenoo, Yi‐Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong‐Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang‐Cheol Bae, Fiona Goldblatt, Sean O'Neill, Kristine (Pek Ling) Ng, Annie Law, B. M. D. B. Basnayake, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, Shirley Chan, C. S. Lau, Vera Golder, Alberta Hoi, Shereen Oon, Eric Morand, Mandana Nikpour, for the Asia‐Pacific Lupus Collaboration   +39 more
wiley   +1 more source

Clinical features of hearing loss and genotype-phenotype correlations in Alport syndrome caused by COL4A4 or COL4A5 variants. [PDF]

Sci Rep
Matsuzaki S, Nara K, Mutai H, Katsunuma S, Sakamoto H, Hirose M, Wakisaka N, Adachi N, Asanuma S, Fujioka M, Matsunaga T.   +10 more
europepmc   +1 more source

Scavenging of Isolevuglandins Attenuates Neutrophil Migration and Neutrophil Extracellular Trap Formation in Systemic Lupus Erythematosus

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Systemic lupus erythematosus (SLE) is an autoimmune disease that affects numerous organs. Neutrophil extracellular traps (NETs) contribute to sterile inflammation and autoantibody generation in SLE. Isolevuglandins (isoLGs) are reactive oxygen species that are formed during NETosis and contribute to chromatin expansion.
Jaya Krishnan, Néstor de la Visitación, Johnson C. Phung, Jonathan M. Williams, Leslie J. Crofford, Matthew Alexander, David M. Patrick, Anna E. Patrick   +7 more
wiley   +1 more source

Case report: Surgical and clinical results in bilateral lenticonus due to Alport syndrome. [PDF]

Rom J Ophthalmol
Çakmak-Cengiz E, Karaman-Atasever F, Can E.   +2 more
europepmc   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting–Adjusted Comparison to a Historical Control Group Treated With Belimumab

Arthritis &Rheumatology, Volume 78, Issue 3, Page 684-694, March 2026.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo, Shu Su, Jingyue Liu, Junyu Lin, Jin Song, Zongwen Chen, Yuanyuan Peng, Lijun Jiang, Meng Jia, Li Wang, Xinhui Jiang, Wei Zhang, Zanhua Rong, Bo Zhao, Yajun Wang, Xuemei Tang   +15 more
wiley   +1 more source

Autosomal recessive Alport syndrome caused by a novel mutation of COL4A3 gene： one case report with a literature review

Linchuang shenzangbing zazhi, 2022
Yuan-jie Zhu, Zhi-juan Hu
doaj  

A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN. [PDF]

BMC Nephrol
Ozcan SG, Koc E, Murt A, Dincer MT, Gurses I, Seyahi N, Trabulus S.   +6 more
europepmc   +1 more source